What's New in Topical Treatment for Actinic Keratosis
In this one-hour CME webinar, participants will learn the latest information on new topical therapeutic considerations for actinic keratosis, including the recently approved SrC kinase inhibitor.
Upon completion of this live CE webinar, learners should be able to:
- Summarize new topical therapeutic strategies for the management of actinic keratosis
- Differentiate new treatment approaches from current, established AK therapy
- Select patients most appropriate for treatment with new topical therapy options
Hosted By ODAC
In Partnership With The Journal of Drugs in Dermatology
FACULTY
Neal Bhatia, MD
Director of Clinical Dermatology
Therapeutics Clinical Research
